Actinogen Medical Ltd has released a press release.
R&D Tax Rebate
Filed with ASX ·
On 6ix: 6ix.com/news/randd-tax-rebate-2
6ix hasn’t read this filing yet.
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- New Patents Allowed for B-HSD1 Inhibitor
- Further results in bio-ethanol test program
- Announcement of non-renounceable rights issue
- Appendix 4C & Commentary
- Landmark Research on Excess Cortisol & Alzheimers Disease
Later from Actinogen Medical
- FDA Feedback on Xanamem Alzheimers Trail
- Significant Advance in Development of Alzheimers Drug
- FDA Approval to Commence Alzheimers Disease Clinical Trial
- Appendix 4C - quarterly
- Xanamem Research Published in Prestigious Medical Journal
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical